Healthcare Contract Research Organization (CRO) Market is Projected to Jump USD 54.82 Billion by 2026
Recent study titled, Healthcare Contract Research Organization (CRO) Market By Global Industry Size, Share, Trends and Forecast 2018 to 2026 which covers clear verifiable examination and lights up feature components and examples that give an extensive picture of the business.
The global healthcare contract research organization (CRO) market is anticipated to expand at a stable CAGR above 6.5% during the forecast period 2018 to 2026. Increasing preferences for outsourcing activities due to cost and time efficiency and increasing Ramp;D investments have increased the growth of the global healthcare contract research organization (CRO) market. The healthcare contract research organization (CRO) market in the North America is likely to expand at significant CAGR due to numerous advancements in healthcare infrastructure and presence of large number of pharmaceutical and biotechnology organizations in the region.
Growing clinical trials to boost the growth of the clinical segment
In terms of type, the global healthcare contract research organization (CRO) market is bifurcated into drug discovery, pre-clinical and clinical. Clinical segment accumulated the highest market share in 2017 and anticipated to dominate the market throughout the forecast period. The growth of the market can be attributed to various factors such as increase in clinical trial activities, increased Ramp;D investments of pharmaceutical and biopharmaceutical companies, and rising biologics and biosimilars markets. This is increasing the growth of the clinical segment. Technological advancements in medical devices, adoption of point-of-care (POC) testing and increasing incidence of chronic diseases are the major factors supporting the growth of clinical segment. The clinical segment can further be divided into phase I, phase II, phase III, and phase IV trial services. Phase III segment is expected to show significant growth during the forecast period. Furthermore, pre-clinical segment is also forecasted to grow at considerable pace throughout the forecast period as it involve testing on animals in order to accomplish approval of clinical trial on human subjects.
Download Report Sample Pages For Better Understanding at https://www.acumenresearchandconsulting.com/request-sample/934
On the other hand, on the basis of service, the clinical monitoring service segment accumulated the highest revenue share in 2017 owing to the growing health concerns among people and increasing spending on clinical technologies. For relatively recent years, CROs are outsourcing clinical research because of different reasons, for example, cost adequacy, skill, and reduced burden on management. Changing business sector patterns are convincing pharmaceutical organizations to diminish their settled expenses in order to offer effective solutions.
Development of healthcare infrastructure and improving economic conditions in Asia Pacific to create more opportunities in the market
Geographically, the global healthcare contract research organization (CRO) market has been divided into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. In 2017, Asia Pacific was the dominant revenue contributing region owing to, improving economic conditions, large and diverse patient pool and development in healthcare infrastructure in various countries such as India, China and Japan. Expanding enthusiasm of the western association to explore new chances and to extend their geological presence are probably going to drive the development of the regional market. Moreover, growing frequency of lifestyle diseases, such as hypertension, mellitus, and diabetes because of increment in stationary way of life and changing dietary propensities is additionally anticipated to feed the development of the market in Asia Pacific. North America is also projected to grow at significant rate over the forecast period due to majority of outsourcing activities, growing per capita expenditure on healthcare industry and increasing focus on minimizing Ramp;D cost. Additionally, North America is leading region to perform large number of clinical trials worldwide. Europe is also projected to grow significantly over the forecast period.
Quintiles, HARTMANN, Pharmaceutical Product Development, Covance, are likely to continue their domination in global healthcare contract research organization (CRO) market.
The company profiling of key players in the global healthcare contract research organization (CRO) market includes company overview, major business strategies and revenues. The key players of the market are Quintiles, LLC (PPD), PAREXEL International Corporation, Medidata Solutions, Pharmaceutical Product Development Charles River Laboratories (CRL), Covance, PRA Health Sciences ICON Plc, and inVentiv Health Inc. Leading industry participant are primarily focusing on strategic collaborations and Ramp;D in order to provide cost and time efficient solutions to clients.
TABLE OF CONTENT
CHAPTER 1. INDUSTRY OVERVIEW
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
CHAPTER 4. HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET BY PRODUCT
CHAPTER 5. HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET BY SERVICE
CHAPTER 6. NORTH AMERICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET BY COUNTRY
CHAPTER 7. EUROPE HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET BY COUNTRY
CHAPTER 8. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET BY COUNTRY
CHAPTER 9. LATIN AMERICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET BY COUNTRY
CHAPTER 10. MIDDLE EAST HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET BY COUNTRY
CHAPTER 11. AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET BY COUNTRYCHAPTER 12. COMPANY PROFILE CHAPTER 13. RESEARCH APPROACH
Would like to place an order or any question, please feel free to contact firstname.lastname@example.org| +1 407 915 4157
The report is readily available and can be dispatched immediately after payment confirmation.
Buy this premium research report at https://www.acumenresearchandconsulting.com/buy-now/0/934